A one-size-fits-all approach to prediabetes treatment may miss the opportunity to implement an early, more intensive, tailored prevention approach for those with the highest risk of developing type 2 diabetes, according to preliminary research presented at the American Heart Association’s EPI|Lifestyle Scientific Sessions 2026. The meeting is being held in Boston, March 17–20, 2026, and offers the latest science on epidemiological science on prevention, lifestyle and cardiometabolic health.
This article was originally published on MedicalXpress.com
